Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fruchart

Showing results (471-480 of 562) with videos related to

Pageof 57
Sort By:
Gynecologic and Obstetric Investigation|January 1, 1989
Apolipoproteins in human amniotic fluid: concentrations, isoforms and polymorphismA Steinmetz, M Sefraoui, E Scheffler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1995
Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particlesE Cavallero, F Brites, B Delfly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 2000
Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic miceA Tailleux, M Bouly, G Luc, et al.
The Journal of Biological Chemistry|June 22, 2001
Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein betaP Gervois, N Vu-Dac, R Kleemann, et al.
Revue D'Epidemiologie Et De Sante Publique|January 1, 1995
The effect of diet on lipid, apoprotein and lipoparticle variation in the ECTIM study in BelfastF Kee, J Weston, E E McCrum, et al.
Gene|April 24, 1995
A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic miceG L Tremp, N Duchange, D Branellec, et al.
The Journal of Clinical Investigation|August 6, 1998
Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoidsN Vu-Dac, P Gervois, I P Torra, et al.
Clinical Science (London, England : 1979)|February 27, 2001
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemiaA Boullier, N Hennuyer, A Tailleux, et al.
Monographs on Atherosclerosis|January 1, 1985
Mapping of lipoprotein particles with monoclonal antibodies in diabetes and atherosclerosisC Fievet, H Parra, I Luyeye, et al.
European Journal of Clinical Investigation|December 21, 2000
Angiotensin II type-I receptor and ACE polymorphisms and risk of myocardial infarction in men and womenF Kee, C Morrison, O Poirier, et al.
Pageof 57

Showing results (471-480 of 562) with videos related to

Sort By:
Pageof 57
Gynecologic and Obstetric Investigation|January 1, 1989
Apolipoproteins in human amniotic fluid: concentrations, isoforms and polymorphismA Steinmetz, M Sefraoui, E Scheffler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1995
Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particlesE Cavallero, F Brites, B Delfly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 2000
Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic miceA Tailleux, M Bouly, G Luc, et al.
The Journal of Biological Chemistry|June 22, 2001
Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein betaP Gervois, N Vu-Dac, R Kleemann, et al.
Revue D'Epidemiologie Et De Sante Publique|January 1, 1995
The effect of diet on lipid, apoprotein and lipoparticle variation in the ECTIM study in BelfastF Kee, J Weston, E E McCrum, et al.
Gene|April 24, 1995
A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic miceG L Tremp, N Duchange, D Branellec, et al.
The Journal of Clinical Investigation|August 6, 1998
Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoidsN Vu-Dac, P Gervois, I P Torra, et al.
Clinical Science (London, England : 1979)|February 27, 2001
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemiaA Boullier, N Hennuyer, A Tailleux, et al.
Monographs on Atherosclerosis|January 1, 1985
Mapping of lipoprotein particles with monoclonal antibodies in diabetes and atherosclerosisC Fievet, H Parra, I Luyeye, et al.
European Journal of Clinical Investigation|December 21, 2000
Angiotensin II type-I receptor and ACE polymorphisms and risk of myocardial infarction in men and womenF Kee, C Morrison, O Poirier, et al.
Pageof 57